Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Dual NOS/COX inhibitors claimed by SCRAS

March 24, 1997

New salts of known antimigraine agent from Glaxo Wellcome

March 24, 1997

5-HT1A antagonists from American Home Products

March 24, 1997

SCRAS describes galanthamine derivatives

March 24, 1997

Quadramet enters phase I for arthritis

March 21, 1997

FDA clears midazolam for use in children

March 21, 1997

3-D structure of adenylyl cyclase core determined

March 21, 1997

Sagami prepares angiotensin IV agonists

March 21, 1997

Antihyperalgesic effects of bradykinin B2 antagonist from Fujisawa

March 19, 1997

FDA approves Ohmeda's neuromuscular blocking agent

March 19, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...